Answers are grounded in this paper and cite their sources.
Historically, cobalt(II) complexes have been shown to be highly potent catalytic chain transfer agents (CCTAs) in the linear or crosslinking polymerization of methacrylates. These transition metal species reversibly abstract hydrogen atoms (H˙) from propagating chains (P n ˙), terminating them as alkenes (P n =), and add them to monomers (M) to form new chains; this process is mechanistically categorized as a metal-hydride hydrogen atom transfer (MHAT). State-of-the-art CCTAs that perform this catalysis, however, remain challenging synthetic targets with poor general solubility and large batch-to-batch variabilities in performance. Prompted by these shortcomings, we present here the synthesis, evaluation and discovery of DiCoBr 2 , a highly active cobalt(III) precatalyst which was found using a crosslinking photopolymerization platform as a screening tool. This scalable and broadly soluble precatalyst undergoes in situ reduction to the active species under free radical polymerization conditions. The performance, application to control the mechanical properties of both bulk organic and hydrogel materials and mechanism of action of these cobalt-based precatalysts are presented here, revealing a previously overlooked, highly competent ligand scaffold for MHAT catalysis with applications far beyond what is presented.
No takes yet. Share an insight, caveat, or question.
Kosak et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: